S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The single greatest medical breakthrough of all time? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Prosecutor: Evidence shows Trump 'explicitly' OK'd tax fraud
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Why CSL Ltd Stock Could Be Worth a Look
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
EXPLAINER: What's the effect of Russian oil price cap, ban?
MarketBeat: Week in Review 11/28 – 12/02
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The single greatest medical breakthrough of all time? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Prosecutor: Evidence shows Trump 'explicitly' OK'd tax fraud
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Why CSL Ltd Stock Could Be Worth a Look
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
EXPLAINER: What's the effect of Russian oil price cap, ban?
MarketBeat: Week in Review 11/28 – 12/02
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The single greatest medical breakthrough of all time? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Prosecutor: Evidence shows Trump 'explicitly' OK'd tax fraud
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Why CSL Ltd Stock Could Be Worth a Look
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
EXPLAINER: What's the effect of Russian oil price cap, ban?
MarketBeat: Week in Review 11/28 – 12/02
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Today Only: Get a 4K Camera Drone for Just $80
The single greatest medical breakthrough of all time? (Ad)
Pentagon debuts its new stealth bomber, the B-21 Raider
Prosecutor: Evidence shows Trump 'explicitly' OK'd tax fraud
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Why CSL Ltd Stock Could Be Worth a Look
Group of Seven nations and Australia join EU in setting $60-per-barrel price cap on Russian oil
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
EXPLAINER: What's the effect of Russian oil price cap, ban?
MarketBeat: Week in Review 11/28 – 12/02

STRATA Skin Sciences - SSKN Stock Forecast, Price & News

$0.86
0.00 (0.00%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.85
$0.87
50-Day Range
$0.79
$0.96
52-Week Range
$0.74
$1.82
Volume
22,277 shs
Average Volume
7,876 shs
Market Capitalization
$29.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

STRATA Skin Sciences MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
132.9% Upside
$2.00 Price Target
Short Interest
Bearish
0.72% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.20) to ($0.11) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.56 out of 5 stars

Medical Sector

938th out of 1,034 stocks

Surgical & Medical Instruments Industry

97th out of 104 stocks

SSKN stock logo

About STRATA Skin Sciences (NASDAQ:SSKN) Stock

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC and Pharos excimer lasers, VTRAC lamp systems, and TheraClear treatment systems that are used for the treatment of psoriasis, vitiligo, acne, and other skin conditions. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Stock News Headlines

Strata Skin Sciences's Earnings Outlook
Strata Skin Sciences Earnings Preview
See More Headlines
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

SSKN Company Calendar

Last Earnings
11/10/2021
Today
12/03/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/20/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SSKN
Employees
115
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Forecasted Upside/Downside
+132.9%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-2,710,000.00
Pretax Margin
-17.93%

Debt

Sales & Book Value

Annual Sales
$29.98 million
Book Value
$0.63 per share

Miscellaneous

Free Float
20,684,000
Market Cap
$29.82 million
Optionable
Not Optionable
Beta
1.77

Social Links


Key Executives

  • Mr. William D. Humphries M.B.A. (Age 56)
    Exec. Chairman
    Comp: $70.58k
  • Mr. Robert J. Moccia (Age 63)
    Pres, CEO & Director
    Comp: $818.1k
  • Mr. Christopher Lesovitz (Age 40)
    Chief Financial Officer
    Comp: $527.12k
  • Mr. Jay Sturm (Age 66)
    Gen. Counsel & Corp. Sec.
  • Keith Simeone
    VP of Sales
  • Dr. Darrell S. Rigel (Age 71)
    Chief Medical Advisor
  • Mr. Shmuel Gov
    Exec. VP & GM
  • Mr. Michael E. Goodman
    Head of International Sales
  • Mr. Nikolai Kabelev (Age 46)
    VP of R&D
  • Mr. Michael R. Stewart (Age 65)
    Independent Consultant













SSKN Stock - Frequently Asked Questions

What is STRATA Skin Sciences' stock price forecast for 2023?

0 Wall Street research analysts have issued 1 year price targets for STRATA Skin Sciences' shares. Their SSKN share price forecasts range from $2.00 to $2.00. On average, they predict the company's share price to reach $2.00 in the next year. This suggests a possible upside of 132.9% from the stock's current price.
View analysts price targets for SSKN
or view top-rated stocks among Wall Street analysts.

How have SSKN shares performed in 2022?

STRATA Skin Sciences' stock was trading at $1.4650 at the start of the year. Since then, SSKN stock has decreased by 41.4% and is now trading at $0.8588.
View the best growth stocks for 2022 here
.

When is STRATA Skin Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 20th 2023.
View our SSKN earnings forecast
.

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) posted its quarterly earnings data on Wednesday, November, 10th. The medical device company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.03. The medical device company had revenue of $7.71 million for the quarter, compared to analyst estimates of $7.78 million. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 26.52% and a negative net margin of 17.86%. During the same period in the prior year, the business posted ($0.04) EPS.

When did STRATA Skin Sciences' stock split?

STRATA Skin Sciences's stock reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What guidance has STRATA Skin Sciences issued on next quarter's earnings?

STRATA Skin Sciences issued an update on its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $33.00 million-$35.00 million, compared to the consensus revenue estimate of $34.08 million.

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX).

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Nantahala Capital Management LLC (12.65%), Renaissance Technologies LLC (3.28%), Essex Investment Management Co. LLC (1.21%) and Creative Planning (0.29%). Insiders that own company stock include Christopher Lesovitz, Robert Joseph Moccia, Samuel Rubinstein and William D Humphries.
View institutional ownership trends
.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STRATA Skin Sciences' stock price today?

One share of SSKN stock can currently be purchased for approximately $0.86.

How much money does STRATA Skin Sciences make?

STRATA Skin Sciences (NASDAQ:SSKN) has a market capitalization of $29.82 million and generates $29.98 million in revenue each year. The medical device company earns $-2,710,000.00 in net income (profit) each year or ($0.17) on an earnings per share basis.

How many employees does STRATA Skin Sciences have?

The company employs 115 workers across the globe.

How can I contact STRATA Skin Sciences?

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The official website for the company is www.strataskinsciences.com. The medical device company can be reached via phone at (215) 619-3200, via email at bob@lifesciadvisors.com, or via fax at 215-619-3208.

This page (NASDAQ:SSKN) was last updated on 12/3/2022 by MarketBeat.com Staff